- Home
- FBLG vs ANEB Comparison
FBLG vs ANEB Comparison
Compare FBLG & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLG
- ANEB
- Stock Information
- Founded
- FBLG 2021
- ANEB 2020
- Country
- FBLG United States
- ANEB United States
- Employees
- FBLG N/A
- ANEB N/A
- Industry
- FBLG
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- FBLG
- ANEB Health Care
- Exchange
- FBLG NYSE
- ANEB Nasdaq
- Market Cap
- FBLG 37.1M
- ANEB 39.0M
- IPO Year
- FBLG 2024
- ANEB 2021
- Fundamental
- Price
- FBLG $0.84
- ANEB $0.98
- Analyst Decision
- FBLG Strong Buy
- ANEB Buy
- Analyst Count
- FBLG 4
- ANEB 1
- Target Price
- FBLG $13.00
- ANEB $8.00
- AVG Volume (30 Days)
- FBLG 216.9K
- ANEB 11.4K
- Earning Date
- FBLG 05-23-2025
- ANEB 05-19-2025
- Dividend Yield
- FBLG N/A
- ANEB N/A
- EPS Growth
- FBLG N/A
- ANEB N/A
- EPS
- FBLG N/A
- ANEB N/A
- Revenue
- FBLG N/A
- ANEB N/A
- Revenue This Year
- FBLG N/A
- ANEB N/A
- Revenue Next Year
- FBLG N/A
- ANEB N/A
- P/E Ratio
- FBLG N/A
- ANEB N/A
- Revenue Growth
- FBLG N/A
- ANEB N/A
- 52 Week Low
- FBLG $0.76
- ANEB $0.80
- 52 Week High
- FBLG $13.59
- ANEB $3.18
- Technical
- Relative Strength Index (RSI)
- FBLG 38.81
- ANEB 37.00
- Support Level
- FBLG $0.79
- ANEB $0.97
- Resistance Level
- FBLG $0.93
- ANEB $1.30
- Average True Range (ATR)
- FBLG 0.11
- ANEB 0.10
- MACD
- FBLG -0.03
- ANEB -0.00
- Stochastic Oscillator
- FBLG 9.31
- ANEB 1.55
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.